A CRISPR-based system that erases itself from fly populations may offer a safer approach to tackling insecticide resistance ...
AppLovin Meta Platforms and Alphabet’s recent earnings reports show that the advertising market has bounced back from a rut, but that doesn’t mean it won’t run into trouble. AppLovin stock surged on ...
The lab of Dr. Mark Magnuson, Louise B. McGavock Professor and professor of molecular physiology and biophysics at Vanderbilt ...
Stifel analysts adjusted their outlook on CRISPR Therapeutics (NASDAQ:CRSP), currently trading at $43.09 with a market capitalization of $3.7 billion, reducing the price target to $49 from the ...
Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...
Biomedical engineers at Duke University have demonstrated a promising new approach that could be used to treat a rare and ...
Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically ...
CRISPR Therapeutics AG (CRSP) stock jumped over 9% this week after delivering strong Q4 2024 results ahead of schedule. The ...
Shares of GE HealthCare Technologies rose early Thursday after the medical imaging company reported better-than-expected ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on aTyr Pharma (ATYR – Research Report), Crispr Therapeutics AG ...
No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...
Crispr Therapeutics (CRSP) has disclosed a new risk, in the Innovation / R&D category. Crispr Therapeutics faces a significant business risk due ...